Mandate

Vinge has advised Nextmune and Spectrum Veterinary in connection with acquisition of operations from ALK

November 28, 2019 M&A

Vinge has advised Nextmune and its U.S. subsidiary Spectrum Veterinary, LLC, in connection with the acquisition of U.S. veterinary allergy testing and treatment activities from ALK.

Vinge’s team consisted of, among others, Jonas Bergström and Manne Bergström.

Related

Vinge advises Calliditas Therapeutics in connection with Asahi Kasei Corporation’s public takeover offer

On 28 May 2024, Asahi Kasei Corporation announced a public takeover offer to the shareholders and holders of American Depositary Shares in Calliditas Therapeutics AB (publ) (”Calliditas Therapeutics”) to acquire all shares and American Depositary Shares (each representing two shares) in Calliditas Therapeutics.
May 28, 2024

Vinge has advised Alder on the establishment of Alder III

Vinge has advised Alder on the establishment of Alder's third and largest fund to date, Alder III.
May 27, 2024